Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Zhejiang DTRM Biopharma
Novartis
Mayo Clinic
Alliance for Clinical Trials in Oncology
Novartis
Swiss Cancer Institute
SWOG Cancer Research Network
M.D. Anderson Cancer Center
City of Hope Medical Center
Technical University of Munich